Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial-Reference-Cited by-同舟云学术

Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial

Published:2020-12 Issue: Volume:320 Page:27-34
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Takahashi Kuniaki,Wang Rutao,Kawashima Hideyuki,Tomaniak Mariusz,Gao Chao,Ono Masafumi,Hara Hironori,Wykrzykowska Joanna J.,de Winter Robbert J.,Werner Nikos,Teiger Emmanuel,Almeida Manuel,Barraud Pascal,Lantelme Pierre,Barlis Peter,Garg Scot,Hamm Christian,Steg Philippe Gabriel,Onuma Yoshinobu,Vranckx Pascal,Windecker Stephan,Valgimigli Marco,Serruys Patrick W.

Funder

AstraZeneca

Biosensors

The Medicines Company

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function;Leaman;Circulation.,1981

2. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery;Klein;Am. J. Cardiol.,1986

3. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction;Karha;Am. J. Cardiol.,2003